SCHEMBL5598982

SCHEMBL5598982

Cc1ccc(C(=O)N2c3ccc(F)cc3C3(CCNCC3)[C@H]2CC2CC2)cc1[N+](=O)[O-]

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.43
HTT P42858 4/20 0.42
ALDH1A1 P00352 9/20 0.41
SMN1; SMN2 Q16637 5/20 0.41
GAA P10253 4/20 0.38
L3MBTL1 Q9Y468 2/20 0.36
HSP90AA1 P07900 1/20 0.36
TSHR P16473 1/20 0.35
GNRHR P30968 1/20 0.34
KCNH2 Q12809 1/20 0.34
MAPT P10636 4/20 0.34
LMNA P02545 2/20 0.34
MEN1 O00255 2/20 0.34
NPBWR1 P48145 1/20 0.34
MCHR1 Q99705 1/20 0.34
MAPK1 P28482 1/20 0.33
SLC12A2 P55011 1/20 0.33
SLC12A5 Q9H2X9 1/20 0.33
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5784831 0.88 KMT2A (0.42) KMT2AHTTALDH1A1SMN1; SMN2GAA
SCHEMBL5599578 0.87 HSD11B1 (0.40) HTTALDH1A1L3MBTL1GNRHRKCNH2
SCHEMBL5787489 0.85 HSD11B1 (0.43) KMT2AALDH1A1MEN1MAPK1
SCHEMBL5599242 0.82 CYP3A4 (0.38) KMT2AHTTALDH1A1SMN1; SMN2GAA
SCHEMBL5780895 0.82 PSEN1 (0.40) GNRHRKCNH2
SCHEMBL5600630 0.80 GNRHR (0.36) HTTALDH1A1TSHRGNRHRKCNH2
SCHEMBL5781400 0.80 HSD11B1 (0.35) GNRHRKCNH2
SCHEMBL5783881 0.80 TSHR (0.49) ALDH1A1SMN1; SMN2GAAL3MBTL1TSHR
SCHEMBL5599733 0.79 HSD11B1 (0.40) HTTALDH1A1SMN1; SMN2L3MBTL1GNRHR
SCHEMBL5600187 0.78 HSD11B1 (0.41) KMT2ASMN1; SMN2KCNH2LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005063745-A9 NOVEL SPIROINDOLINE OR SPIROISOQUINOLINE COMPOUNDS, METHODS OF USE AND COMPOSITIONS THEREOF ARENA PHARM INC (US) 2007-02-01 WO claimed